Pharma Journalist 8801 posts 0 comments

Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), and Servier, an international pharmaceutical company,…
Read More...

Biotage AB (Biotage) announced the launch of a Good Laboratory Practices (GLP) software upgrade for Biotage Extrahera, their flagship automated sample preparation instrument for…
Read More...

Aphena Pharma Solutions Inc. has announced the expansion of its bottling capacity with the purchase of a new, state-of-the-art, high-speed, solid-dose bottling line with an integrated…
Read More...

m8 Pharmaceuticals and Vectans Pharma, announced they have signed an exclusive licensing agreement whereby m8 will have the rights to register and commercialize Loramyc (miconazole) for…
Read More...

Sanofi Pasteur, the vaccines global business unit of Sanofi, will leverage previous development work for a SARS vaccine which may unlock a fast path forward for developing a COVID-19…
Read More...

Audentes Therapeutics, an Astellas company focused on developing innovative AAV-based genetic medicines, announced that it plans to invest $109 million to build a new 135,000 square…
Read More...

Pfizer Inc. announced that the European Commission (EC) has approved VYNDAQEL (tafamidis), a once-daily 61 mg oral capsule, for the treatment of wild-type or hereditary transthyretin…
Read More...

Arrevus, a clinical stage biopharmaceutical company committed to the development of innovative therapies to treat orphan or serious diseases, announced that the U.S. Food and Drug…
Read More...

Univercells, an innovative bioprocessing provider focused on increasing the availability of affordable biologics to address global health challenges, has announced up to EUR 50M…
Read More...

GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever) as…
Read More...